Kiora Pharmaceuticals Inc (KPRX) — Cash Flow Reinvestment Rate

Latest as of September 2024: 2.09x

Kiora Pharmaceuticals Inc (KPRX) has a Cash Flow Reinvestment Rate of 2.09x as of September 2024, reinvesting $1.92 Million (capex $3.00 plus investments $-1.92 Million) from operating cash flow of $920.06K. See Kiora Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

2.09x
(Capex + Investments) / Operating CF

Total Reinvested

$1.92 Million
Capex + Investments

Operating Cash Flow

$920.06K
USD

Capital Expenditures

$3.00
USD

Kiora Pharmaceuticals Inc Cash Flow Reinvestment Rate (2024–2024)

Historical reinvestment intensity for Kiora Pharmaceuticals Inc across 1 annual periods. For the full cash flow conversion analysis, see Kiora Pharmaceuticals Inc (KPRX) cash flow conversion.

Annual Cash Flow Reinvestment Rate for Kiora Pharmaceuticals Inc (2024–2024)

Year-by-year capital reinvestment analysis for Kiora Pharmaceuticals Inc. See financial agility of Kiora Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2024 2.65x $22.67 Million $8.56 Million $6.26K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow